Asensus Surgical Inc (ASXC) Stock
ASXC is no longer traded. Asensus Surgical was delisted from the NYSE American in August 2024.
Prices on this page are historical; the last trade was August 21, 2024 at $0.35.
Asensus Surgical stock price history
ASXC final trading statistics
- Final close
- $0.35
- Final trading day
- Aug 21, 2024
- Market cap at delisting
- $94.92M
- Shares outstanding
- 272.84M
- Final 52-week range
- $0.17 – $0.40
- Avg. volume (final 3 mo.)
- 3,005,948
- All-time high (split-adj.)
- $13893.75 · Nov 1996
- All-time low (split-adj.)
- $0.21 · Oct 2023
- Return since IPO
- -100.0%
- Beta
- 1.38
- Book value / share
- -$0.04
- Price / book
- -8.28
Asensus Surgical annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $8.58M | -$78.4M | -$0.31 |
| FY2022 | $7.09M | -$75.6M | -$0.32 |
| FY2021 | $8.23M | -$62.5M | -$0.24 |
| FY2020 | $3.17M | -$59.3M | -$0.83 |
| FY2019 | $8.53M | -$154.2M | -$4.34 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Asensus Surgical Inc
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.
Asensus Surgical stock FAQ
What happened to Asensus Surgical stock?
Asensus Surgical stock was delisted from the NYSE American. Its final close was $0.35 on August 21, 2024.
Is ASXC stock still trading?
No. ASXC was delisted from the NYSE American in August 2024 and no longer trades on a U.S. exchange.
What was the last price of ASXC stock?
ASXC closed at $0.35 on its final trading day, August 21, 2024, for a market value of about $94.92M.
What were Asensus Surgical's revenue and earnings in its last full fiscal year?
Asensus Surgical reported revenue of $8.58M and net income of -$78.4M in fiscal 2023, its last full year as a public company.
When did Asensus Surgical go public?
Asensus Surgical Inc stock began trading on November 12, 1992.